AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ubbink, J. B.
Right arrow Articles by de Villiers, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ubbink, J. B.
Right arrow Articles by de Villiers, L. S.
Agricola
Right arrow Articles by Ubbink, J. B.
Right arrow Articles by de Villiers, L. S.

American Journal of Clinical Nutrition, Vol 46, 78-85, Copyright © 1987 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Effect of different levels of oral pyridoxine supplementation on plasma pyridoxal-5'-phosphate and pyridoxal levels and urinary vitamin B-6 excretion

JB Ubbink, WJ Serfontein, PJ Becker and LS de Villiers

Plasma pyridoxal-5'-phosphate and pyridoxal levels increased significantly (p less than 0.05) when single, oral bolus doses of pyridoxine were increased from 10 to 25 and from 25 to 50 mg in nine female volunteers. However, when the dose was increased to 100 mg, plasma pyridoxal-5'-phosphate levels did not differ significantly from those recorded after the 50 mg dose. Within 3 h plasma pyridoxal levels rose with a factor of 3.85 compared with the 50 mg dose but high pyridoxal levels were eliminated from the circulation. Renal clearance of pyridoxal remained a constant, low percentage (less than 2.0%) of each pyridoxine supplement in spite of the observed very high circulating pyridoxal levels. Pyridoxine supplementation is discussed in relation to circulating pyridoxal-5'-phosphate and pyridoxal availability for cellular metabolism.


This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
O. Midttun, S. Hustad, J. Schneede, S. E Vollset, and P. M Ueland
Plasma vitamin B-6 forms and their relation to transsulfuration metabolites in a large, population-based study
Am. J. Clinical Nutrition, July 1, 2007; 86(1): 131 - 138.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J.-C. Tardif, M. Carrier, D. E. Kandzari, R. Emery, R. Cote, T. Heinonen, M. Zettler, V. Hasselblad, M.-C. Guertin, R. A. Harrington, et al.
Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: Results of the MEND-CABG randomized study
J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1604 - 1611.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. V. Bor, H. Refsum, M. R. Bisp, O. Bleie, J. Schneede, J. E. Nordrehaug, P. M. Ueland, O. K. Nygard, and E. Nexo
Plasma Vitamin B6 Vitamers before and after Oral Vitamin B6 Treatment: A Randomized Placebo-controlled Study
Clin. Chem., January 1, 2003; 49(1): 155 - 161.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by The American Society for Nutrition